Table 1.
Summary of demographics and sample information
| Group | Healthy | Exposed | Infected | Hospitalized | Total | |
|---|---|---|---|---|---|---|
| Age (mean ± SD [range]) | 39.70 ± 13.68 (25–61) | 42.57 ± 13.93 (17–60) | 36.73 ± 13.88 (20–65) | 59.44 ± 15.11 (31–76) | 42.84 ± 16.06 (17–76) | |
| Number of subjects (female:male [F:M] ratio) | n = 10 (5:5) | n = 7 (3:4) | n = 19 (8:11) | n = 9 (4:5) | n = 45 (20:25) | |
| Race (n [%]) | African American | 3 (30.00%) | 0 | 1 (5.26%) | 5 (55.56%) | 9 (20.00%) |
| Asian | 0 | 1 (14.29%) | 2 (10.53%) | 0 | 3 (6.67%) | |
| White | 7 (70.00%) | 5 (71.42%) | 16 (84.21%) | 3 (33.33%) | 31 (68.89%) | |
| Others/ unknown | 0 | 1 (14.29%) | 0 | 1 (11.11%) | 2 (4.44%) | |
| Days since onset when enrolled (mean ± SD [range]) | N/A | 15.17 ± 11.25 (5–33) | 11.18 ± 4.30 (3–19) | 8.25 ± 6.14 (1–18) | 11.19 ± 6.73 (1–33) | |
| # samples of flow cytometry (F:M ratio) | n = 10 (5:5) | n = 20 (9:11) | n = 44 (21:23) | n = 9 (4:5) | n = 83 (39:44) | |
| # samples of scRNA-seq (F:M ratio) | n = 5 (3:2) | n = 8 (3:5) | n = 29 (12:17) | n = 6 (1:5) | n = 48 (19:29) | |
| Days since onset when samples collected mean ± SD (range) | N/A | 26.94 ± 14.94 (5–61) | 18.27 ± 8.44 (3–40) | 8.25 ± 6.14 (1–18) | 19.32 ± 11.44 (1–61) | |
See also Table S1.